Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Toft

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Brain : a Journal of Neurology|May 29, 2023
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body diseaseJon-Anders Tunold, Manuela M X Tan, Shunsuke Koga, et al.
NPJ Parkinson'S Disease|September 22, 2021
Fine mapping of the HLA locus in Parkinson's disease in EuropeansEric Yu, Aditya Ambati, Maren Stolp Andersen, et al.
European Journal of Human Genetics : EJHG|October 16, 2008
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll, Mathias Toft, Lisa Skipper, et al.
American Journal of Human Genetics|May 11, 2006
Genomewide association, Parkinson disease, and PARK10Matthew J Farrer, Kristoffer Haugarvoll, Owen A Ross, et al.
Biological Psychiatry|March 24, 2020
Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk LociOlav B Smeland, Alexey Shadrin, Shahram Bahrami, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseJan O Aasly, Carles Vilariño-Güell, Justus C Dachsel, et al.
Neurobiology of Aging|February 6, 2018
Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's diseaseCornelis Blauwendraat, Demis A Kia, Lasse Pihlstrøm, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's diseaseManuela Mx Tan, Hirotaka Iwaki, Sara Bandres-Ciga, et al.
Parkinsonism & Related Disorders|August 19, 2019
Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter studyAndreas Puschmann, Itzia Jiménez-Ferrer, Elin Lundblad-Andersson, et al.
Eneuro|June 20, 2025
Evidence That Dmrta2 Acts through Repression of <i>Pax6</i> in Cortical Patterning and Identification of a Mutation Impairing DNA Recognition Associated with Microcephaly in HumanXueyi Shen, Jithu Anirudhan, Ambrin Fatima, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Brain : a Journal of Neurology|May 29, 2023
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body diseaseJon-Anders Tunold, Manuela M X Tan, Shunsuke Koga, et al.
NPJ Parkinson'S Disease|September 22, 2021
Fine mapping of the HLA locus in Parkinson's disease in EuropeansEric Yu, Aditya Ambati, Maren Stolp Andersen, et al.
European Journal of Human Genetics : EJHG|October 16, 2008
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll, Mathias Toft, Lisa Skipper, et al.
American Journal of Human Genetics|May 11, 2006
Genomewide association, Parkinson disease, and PARK10Matthew J Farrer, Kristoffer Haugarvoll, Owen A Ross, et al.
Biological Psychiatry|March 24, 2020
Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk LociOlav B Smeland, Alexey Shadrin, Shahram Bahrami, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseJan O Aasly, Carles Vilariño-Güell, Justus C Dachsel, et al.
Neurobiology of Aging|February 6, 2018
Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's diseaseCornelis Blauwendraat, Demis A Kia, Lasse Pihlstrøm, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's diseaseManuela Mx Tan, Hirotaka Iwaki, Sara Bandres-Ciga, et al.
Parkinsonism & Related Disorders|August 19, 2019
Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter studyAndreas Puschmann, Itzia Jiménez-Ferrer, Elin Lundblad-Andersson, et al.
Eneuro|June 20, 2025
Evidence That Dmrta2 Acts through Repression of <i>Pax6</i> in Cortical Patterning and Identification of a Mutation Impairing DNA Recognition Associated with Microcephaly in HumanXueyi Shen, Jithu Anirudhan, Ambrin Fatima, et al.
Pageof 13